^
    The GenesWell ddEGFR Mutation Test is a companion diagnostics which detects 45 EGFR mutations for non-small cell lung cancer(NSCLC) patients. It selects which NSCLC patients will respond to tyrosine kinase inhibitors such as Tarceva®(Erlotinib) and Tagrisso™(Osimertinib)
    Cancer:
    Non Small Cell Lung Cancer
    Gene:
    EGFR (Epidermal growth factor receptor)
    Drug:
    Tagrisso (osimertinib), erlotinib
    Method:
    PCR